Fourth Annual Psychiatry Summit 2025

Goal Statement
The goal of this program is to improve the knowledge, competence, and performance of learners in applying diagnostic considerations and assessing new and emerging therapies for the treatment of psychiatric disorders. 

Target Audience
This conference is intended for physicians, nurse practitioners, registered nurses, pharmacists, physician associates, social workers, and psychologists engaged in the care of patients with psychiatric illness.

Learning Objectives
Upon completion of this event, participants should be able to:

• Discuss current events and hot topics in psychiatry. 
• Describe best practices for diagnosis and management of psychiatric illness. 
• Assess clinical evidence for new and emerging treatment options for psychiatric disorders

---

Agenda:

Saturday, May 31, 2025

9:00 AM - 9:05 AM: Opening Remarks by moderator Joseph F. Goldberg, MD

9:05 AM - 10:05 AM – From Assessment to Action: Case-Based Insights for Bipolar Depression with Mixed and Anxious Specifiers

Presented by Joseph F. Goldberg, MD

Analyze the complexities of bipolar depression through the lens of DSM-5-TR specifiers (mixed features and anxious distress), including their impact on comorbidity risks and cardiovascular disease in patients experiencing mixed mood episodes. This interactive session combines case-based learning, audience polling on diagnostic challenges, and evidence-based strategies for differentiating bipolar subtypes and tailoring treatments to address mixed features and anxious distress.

5-minute break

10:10 AM - 11:10 AM – Brain Health in Focus: Dementia Prevention and Early Diagnosis in Psychiatric Settings

Presented by Rajeet Shrestha, MD and Amanda Lathia, MD, CMD

Dementia experts deliver cutting-edge, evidence-based education on maintaining brain health, early detection of cognitive decline, and practical strategies for integrating brain health assessments into psychiatric practice. Explore innovative approaches to patient education and communication around management of modifiable risk factors to enhance dementia prevention.

5-minute break

11:15 AM - 12:15 PM – Beyond Dopamine: Innovations in Schizophrenia Treatment and Addressing Unmet Needs

Presented by Roger McIntyre, MD, FRCPC

Emerging research is reshaping schizophrenia care, offering pathways to address persistent symptoms while mitigating adverse events tied to traditional therapies. Interactive case discussions and clinical trial updates highlight new strategies to individualize treatment, improve adherence, and reduce psychosocial burdens for patients navigating the challenges of schizophrenia.

5-minute break

12:20 PM - 1:20 PM – Reproductive Depression: Why Hormones Matter

Presented by Jennifer L. Payne, MD

The impact of estrogen and other reproductive hormones on mood are often neglected as a contributing factor to mental health disorders at many stages over a typical women's lifespan. This presentation will discuss the relevance of reproductive hormones to clinical psychiatry and provide framework for a new paradigm in risk assessment and treatment.

5-minute break

1:25 PM – 2:25 PM –  Beyond Counting Sheep: Evidence-Based Approaches to Insomnia

Presented by Michael Grandner, PhD, MTR, CBSM, FAASM

Discover the science behind slumber as we unravel the complexities of the sleep/wake cycle while exploring risk factors, comorbidities, and pathophysiology behind insomnia. Join us in understanding evidence-based behavioral strategies, while developing expertise in selecting appropriate pharmacologic approaches guided by the latest clinical recommendations to effectively treat chronic insomnia, empowering you to help your patients achieve restorative sleep.

2:25 PM – 2:30 PM: Closing Remarks by moderator Joseph F. Goldberg, MD